Cambridge Trust CO Ginkgo Bioworks Holdings, Inc. Transaction History
Cambridge Trust CO
- $2.6 Billion
- Q1 2024
A detailed history of Cambridge Trust CO transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Cambridge Trust CO holds 200 shares of DNA stock, worth $1,436. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$1,436
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
43Shares Held
48.4MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY42MShares$302 Million0.0% of portfolio
-
Titleist Asset Management, Ltd. San Antonio, TX2.31MShares$16.6 Million0.92% of portfolio
-
Putnam Investments LLC Boston, MA1.5MShares$10.8 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.15MShares$8.23 Million0.0% of portfolio
-
Benjamin F. Edwards & Company, Inc. St. Louis, MO235KShares$1.69 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $9.25B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...